

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 7.42049373 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 6.54425260 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.53016474 |
| 4 | protein localization to synapse (GO:0035418) | 6.39389214 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.58256622 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.54381333 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.51457908 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.47630079 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.38780462 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.24587647 |
| 11 | synaptic vesicle maturation (GO:0016188) | 5.10033223 |
| 12 | glutamate secretion (GO:0014047) | 5.02080002 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.92993866 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.87493940 |
| 15 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.86109415 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.79069959 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.69186823 |
| 18 | gamma-aminobutyric acid transport (GO:0015812) | 4.60268632 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60134024 |
| 20 | indolalkylamine metabolic process (GO:0006586) | 4.52359700 |
| 21 | positive regulation of membrane potential (GO:0045838) | 4.51434738 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.44844655 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.43022220 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.43022220 |
| 25 | tryptophan catabolic process (GO:0006569) | 4.43022220 |
| 26 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.42840744 |
| 27 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.32958977 |
| 28 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.26851469 |
| 29 | neuron-neuron synaptic transmission (GO:0007270) | 4.25169827 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 4.24682393 |
| 31 | striated muscle atrophy (GO:0014891) | 4.18175795 |
| 32 | negative regulation of mast cell activation (GO:0033004) | 4.16603070 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15934605 |
| 34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.10892059 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.09832951 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 4.09632010 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 4.08567504 |
| 38 | interkinetic nuclear migration (GO:0022027) | 4.03995148 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03273670 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.01991616 |
| 41 | proline transport (GO:0015824) | 4.01564191 |
| 42 | kynurenine metabolic process (GO:0070189) | 4.01045240 |
| 43 | tryptophan metabolic process (GO:0006568) | 3.98203493 |
| 44 | startle response (GO:0001964) | 3.98139795 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.96757077 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.95878968 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.88947243 |
| 48 | neurotransmitter transport (GO:0006836) | 3.84025988 |
| 49 | behavioral response to nicotine (GO:0035095) | 3.84023685 |
| 50 | presynaptic membrane assembly (GO:0097105) | 3.81947258 |
| 51 | exploration behavior (GO:0035640) | 3.80234703 |
| 52 | muscle atrophy (GO:0014889) | 3.78694334 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.78260875 |
| 54 | response to inactivity (GO:0014854) | 3.76068654 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74407959 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.64649362 |
| 57 | regulation of synapse maturation (GO:0090128) | 3.63182141 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.61684279 |
| 59 | detection of calcium ion (GO:0005513) | 3.61103547 |
| 60 | long-term memory (GO:0007616) | 3.58730382 |
| 61 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.56372446 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.56081526 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50594411 |
| 64 | membrane hyperpolarization (GO:0060081) | 3.49197616 |
| 65 | neuron recognition (GO:0008038) | 3.49035568 |
| 66 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.47904824 |
| 67 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.45720911 |
| 68 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.45720911 |
| 69 | skeletal muscle tissue regeneration (GO:0043403) | 3.43200840 |
| 70 | presynaptic membrane organization (GO:0097090) | 3.40816414 |
| 71 | long-term synaptic potentiation (GO:0060291) | 3.38031183 |
| 72 | membrane depolarization (GO:0051899) | 3.36661846 |
| 73 | positive regulation of synapse assembly (GO:0051965) | 3.35766790 |
| 74 | regulation of synaptic plasticity (GO:0048167) | 3.35313109 |
| 75 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.34348617 |
| 76 | DNA deamination (GO:0045006) | 3.34303421 |
| 77 | synapse assembly (GO:0007416) | 3.34071772 |
| 78 | sulfation (GO:0051923) | 3.33750679 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.33271229 |
| 80 | regulation of synapse structural plasticity (GO:0051823) | 3.30822363 |
| 81 | learning (GO:0007612) | 3.28806843 |
| 82 | regulation of neurotransmitter secretion (GO:0046928) | 3.27869104 |
| 83 | indole-containing compound metabolic process (GO:0042430) | 3.25783266 |
| 84 | protein K11-linked deubiquitination (GO:0035871) | 3.25166783 |
| 85 | behavioral response to cocaine (GO:0048148) | 3.25078259 |
| 86 | striatum development (GO:0021756) | 3.22436381 |
| 87 | neuronal ion channel clustering (GO:0045161) | 3.18279651 |
| 88 | DNA methylation involved in gamete generation (GO:0043046) | 3.16997614 |
| 89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.16811415 |
| 90 | regulation of vesicle fusion (GO:0031338) | 3.16773006 |
| 91 | intraspecies interaction between organisms (GO:0051703) | 3.15862320 |
| 92 | social behavior (GO:0035176) | 3.15862320 |
| 93 | synaptic transmission (GO:0007268) | 3.15494405 |
| 94 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.15397906 |
| 95 | regulation of synapse assembly (GO:0051963) | 3.09925729 |
| 96 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.09875969 |
| 97 | transferrin transport (GO:0033572) | 3.09715523 |
| 98 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07022126 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 3.06140528 |
| 100 | male meiosis I (GO:0007141) | 3.05680319 |
| 101 | positive regulation of synaptic transmission (GO:0050806) | 3.04527975 |
| 102 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03238375 |
| 103 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02749501 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 3.02074025 |
| 105 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.01448212 |
| 106 | negative regulation of sodium ion transport (GO:0010766) | 3.01129438 |
| 107 | trivalent inorganic cation transport (GO:0072512) | 3.00594403 |
| 108 | ferric iron transport (GO:0015682) | 3.00594403 |
| 109 | synaptic vesicle endocytosis (GO:0048488) | 3.00448733 |
| 110 | regulation of synaptic transmission (GO:0050804) | 2.99966414 |
| 111 | amine catabolic process (GO:0009310) | 2.99106349 |
| 112 | cellular biogenic amine catabolic process (GO:0042402) | 2.99106349 |
| 113 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.98619152 |
| 114 | layer formation in cerebral cortex (GO:0021819) | 2.97821355 |
| 115 | membrane depolarization during action potential (GO:0086010) | 2.97078755 |
| 116 | positive regulation of action potential (GO:0045760) | 2.95484493 |
| 117 | piRNA metabolic process (GO:0034587) | 2.94954430 |
| 118 | regulation of female receptivity (GO:0045924) | 2.93969897 |
| 119 | behavioral response to ethanol (GO:0048149) | 2.93886579 |
| 120 | visual learning (GO:0008542) | 2.92978360 |
| 121 | positive regulation of phosphatase activity (GO:0010922) | 2.92682638 |
| 122 | neural tube formation (GO:0001841) | 2.90295793 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.89557792 |
| 124 | positive regulation of developmental pigmentation (GO:0048087) | 2.89082889 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.88877565 |
| 126 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.88787861 |
| 127 | learning or memory (GO:0007611) | 2.85252457 |
| 128 | memory (GO:0007613) | 2.84892762 |
| 129 | synapse organization (GO:0050808) | 2.84827747 |
| 130 | somite development (GO:0061053) | 2.84295912 |
| 131 | protein K63-linked deubiquitination (GO:0070536) | 2.84132570 |
| 132 | multicellular organismal movement (GO:0050879) | 2.83680231 |
| 133 | musculoskeletal movement (GO:0050881) | 2.83680231 |
| 134 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.83560971 |
| 135 | regulation of skeletal muscle contraction (GO:0014819) | 2.81571475 |
| 136 | detection of light stimulus involved in visual perception (GO:0050908) | 2.81436024 |
| 137 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.81436024 |
| 138 | retinal cone cell development (GO:0046549) | 2.80587452 |
| 139 | response to histamine (GO:0034776) | 2.79892737 |
| 140 | establishment of synaptic vesicle localization (GO:0097480) | 2.79590694 |
| 141 | synaptic vesicle transport (GO:0048489) | 2.79590694 |
| 142 | regulation of dendritic spine development (GO:0060998) | 2.79387655 |
| 143 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.79090410 |
| 144 | axoneme assembly (GO:0035082) | 2.78812065 |
| 145 | regulation of germinal center formation (GO:0002634) | 2.78785645 |
| 146 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.78729812 |
| 147 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.77748754 |
| 148 | cellular response to dexamethasone stimulus (GO:0071549) | 2.77456087 |
| 149 | B cell receptor signaling pathway (GO:0050853) | 2.74756248 |
| 150 | regulation of pigment cell differentiation (GO:0050932) | 2.74373422 |
| 151 | serotonin metabolic process (GO:0042428) | 2.73408359 |
| 152 | skeletal muscle adaptation (GO:0043501) | 2.71905429 |
| 153 | protein polyglutamylation (GO:0018095) | 2.68411780 |
| 154 | primary amino compound metabolic process (GO:1901160) | 2.64638578 |
| 155 | regulation of hippo signaling (GO:0035330) | 2.60489430 |
| 156 | photoreceptor cell maintenance (GO:0045494) | 2.60332426 |
| 157 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.59278062 |
| 158 | microtubule anchoring (GO:0034453) | 2.58691119 |
| 159 | regulation of sarcomere organization (GO:0060297) | 2.58081620 |
| 160 | snRNA transcription (GO:0009301) | 2.53367115 |
| 161 | neuronal action potential (GO:0019228) | 2.53353878 |
| 162 | NAD biosynthetic process (GO:0009435) | 2.52549349 |
| 163 | nucleus localization (GO:0051647) | 2.51266426 |
| 164 | limb development (GO:0060173) | 2.51056157 |
| 165 | appendage development (GO:0048736) | 2.51056157 |
| 166 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.50195270 |
| 167 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.48674039 |
| 168 | cellular response to interleukin-15 (GO:0071350) | 2.48556869 |
| 169 | tachykinin receptor signaling pathway (GO:0007217) | 2.48457479 |
| 170 | protein K48-linked deubiquitination (GO:0071108) | 2.47982420 |
| 171 | regulation of sequestering of triglyceride (GO:0010889) | 2.47414580 |
| 172 | regulation of acrosome reaction (GO:0060046) | 2.47316167 |
| 173 | response to dexamethasone (GO:0071548) | 2.46976069 |
| 174 | male meiosis (GO:0007140) | 2.46809412 |
| 175 | multicellular organism reproduction (GO:0032504) | 2.46419881 |
| 176 | double-strand break repair via homologous recombination (GO:0000724) | 2.44275703 |
| 177 | response to pheromone (GO:0019236) | 2.44145370 |
| 178 | epithelial cilium movement (GO:0003351) | 2.43893963 |
| 179 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.43298462 |
| 180 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.42981028 |
| 181 | response to caffeine (GO:0031000) | 2.42856940 |
| 182 | establishment of protein localization to Golgi (GO:0072600) | 2.41651573 |
| 183 | photoreceptor cell development (GO:0042461) | 2.40681255 |
| 184 | benzene-containing compound metabolic process (GO:0042537) | 2.40301972 |
| 185 | glycosphingolipid biosynthetic process (GO:0006688) | 2.39327708 |
| 186 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.39232732 |
| 187 | rhodopsin mediated signaling pathway (GO:0016056) | 2.37990249 |
| 188 | recombinational repair (GO:0000725) | 2.37436341 |
| 189 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.37323629 |
| 190 | positive regulation of myoblast differentiation (GO:0045663) | 2.36306648 |
| 191 | regulation of meiosis I (GO:0060631) | 2.36032577 |
| 192 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.36025129 |
| 193 | platelet dense granule organization (GO:0060155) | 2.35862981 |
| 194 | reflex (GO:0060004) | 2.35611110 |
| 195 | meiosis I (GO:0007127) | 2.35119311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.29685003 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.43007002 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11698515 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01460554 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93949536 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60244536 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48937320 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48937320 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.48559665 |
| 10 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45531552 |
| 11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41843461 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.37959151 |
| 13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36982690 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29543569 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27795709 |
| 16 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26573889 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25194340 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.23252149 |
| 19 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17860323 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13988660 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13155500 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.12153113 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10824991 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05206340 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.00646007 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98378792 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97997104 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92484901 |
| 29 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91557452 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90001807 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.89914865 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89507596 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88243223 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.86594364 |
| 35 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81136001 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.77665456 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.76187626 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.75065192 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73050030 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72296258 |
| 41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.71727656 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71382845 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70505155 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69324699 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68733457 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68414827 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67691830 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66484140 |
| 49 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.66094273 |
| 50 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.62341996 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60429243 |
| 52 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54053713 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54001260 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52657949 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51544309 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.50984725 |
| 57 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.49882927 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.49624493 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.49624493 |
| 60 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48612326 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.48611946 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47999713 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44275561 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41454698 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40909232 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40233472 |
| 67 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38582085 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38249082 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37234268 |
| 70 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36987555 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36726594 |
| 72 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35290324 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35158627 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34341112 |
| 75 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.34129472 |
| 76 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.32489387 |
| 77 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32058496 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31938129 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30315005 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30114905 |
| 81 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29963783 |
| 82 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29953839 |
| 83 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29566209 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29067002 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28964522 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28486258 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28313024 |
| 88 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.27431326 |
| 89 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.26597908 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26051087 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26035961 |
| 92 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.26035067 |
| 93 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24671586 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23580588 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21791141 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20411737 |
| 97 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19919542 |
| 98 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17669802 |
| 99 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17669802 |
| 100 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17547644 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17454400 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16234803 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15927596 |
| 104 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15589281 |
| 105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15080797 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14630186 |
| 107 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.14047629 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13339047 |
| 109 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12918608 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12663473 |
| 111 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12012359 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11607881 |
| 113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11607881 |
| 114 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10907563 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10629921 |
| 116 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.10535531 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 1.10248468 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09932811 |
| 119 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09677397 |
| 120 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09652680 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09083359 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08739771 |
| 123 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08377133 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08260946 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07007392 |
| 126 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06976479 |
| 127 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06046584 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05564426 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05462592 |
| 130 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05247731 |
| 131 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04587028 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04583521 |
| 133 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04496879 |
| 134 | JUN_21703547_ChIP-Seq_K562_Human | 1.04265736 |
| 135 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04194354 |
| 136 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04183018 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04145686 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03392355 |
| 139 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02671729 |
| 140 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02047553 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01816478 |
| 142 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01278818 |
| 143 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99111541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.73844793 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.21381928 |
| 3 | MP0003880_abnormal_central_pattern | 4.12414152 |
| 4 | MP0009046_muscle_twitch | 3.93154277 |
| 5 | MP0009745_abnormal_behavioral_response | 3.50196983 |
| 6 | MP0002064_seizures | 3.46585447 |
| 7 | MP0004270_analgesia | 3.45574775 |
| 8 | MP0005670_abnormal_white_adipose | 3.43071369 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.27063213 |
| 10 | MP0002735_abnormal_chemical_nociception | 3.24209332 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.98261499 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.95954967 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.94585817 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.89981720 |
| 15 | MP0002272_abnormal_nervous_system | 2.85677729 |
| 16 | MP0008057_abnormal_DNA_replication | 2.77068701 |
| 17 | MP0002822_catalepsy | 2.74443349 |
| 18 | MP0001486_abnormal_startle_reflex | 2.74307460 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.69961083 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.60017984 |
| 21 | MP0002736_abnormal_nociception_after | 2.45276485 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.37239285 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.23034772 |
| 24 | MP0003879_abnormal_hair_cell | 2.20920927 |
| 25 | MP0008569_lethality_at_weaning | 2.13702061 |
| 26 | MP0000372_irregular_coat_pigmentation | 2.08143419 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.08047618 |
| 28 | MP0003195_calcinosis | 2.07294186 |
| 29 | MP0002876_abnormal_thyroid_physiology | 2.06162851 |
| 30 | MP0003787_abnormal_imprinting | 2.04399828 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.97477641 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.96298013 |
| 33 | MP0001970_abnormal_pain_threshold | 1.92703884 |
| 34 | MP0002184_abnormal_innervation | 1.88475979 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.87587238 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.85111519 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.83176344 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.79024701 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.73311963 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.65008552 |
| 41 | MP0004924_abnormal_behavior | 1.65008552 |
| 42 | MP0004130_abnormal_muscle_cell | 1.61406836 |
| 43 | MP0002095_abnormal_skin_pigmentation | 1.59733460 |
| 44 | MP0001188_hyperpigmentation | 1.57122284 |
| 45 | MP0001984_abnormal_olfaction | 1.50421953 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.49724069 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.45756674 |
| 48 | MP0004510_myositis | 1.41662662 |
| 49 | * MP0002066_abnormal_motor_capabilities/c | 1.39837372 |
| 50 | MP0004142_abnormal_muscle_tone | 1.33178492 |
| 51 | MP0000778_abnormal_nervous_system | 1.32898127 |
| 52 | MP0005253_abnormal_eye_physiology | 1.32416729 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.31438877 |
| 54 | MP0005671_abnormal_response_to | 1.30720559 |
| 55 | MP0005389_reproductive_system_phenotype | 1.29565948 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.27362499 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.26463259 |
| 58 | MP0004381_abnormal_hair_follicle | 1.25728324 |
| 59 | MP0000751_myopathy | 1.25639220 |
| 60 | MP0000383_abnormal_hair_follicle | 1.23757328 |
| 61 | MP0001963_abnormal_hearing_physiology | 1.23210612 |
| 62 | MP0000955_abnormal_spinal_cord | 1.22900658 |
| 63 | MP0004858_abnormal_nervous_system | 1.21447471 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.21068724 |
| 65 | MP0004484_altered_response_of | 1.20505069 |
| 66 | MP0003136_yellow_coat_color | 1.20457683 |
| 67 | MP0001800_abnormal_humoral_immune | 1.18538857 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.17294775 |
| 69 | MP0002938_white_spotting | 1.15500101 |
| 70 | MP0004742_abnormal_vestibular_system | 1.14399876 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.13966320 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.12979807 |
| 73 | MP0001529_abnormal_vocalization | 1.07494995 |
| 74 | MP0003329_amyloid_beta_deposits | 1.06559738 |
| 75 | MP0000427_abnormal_hair_cycle | 1.04318475 |
| 76 | MP0003724_increased_susceptibility_to | 1.02313104 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 1.01417026 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.00883594 |
| 79 | MP0001905_abnormal_dopamine_level | 1.00702729 |
| 80 | MP0003646_muscle_fatigue | 0.99547576 |
| 81 | MP0002928_abnormal_bile_duct | 0.98083721 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.97915556 |
| 83 | MP0003633_abnormal_nervous_system | 0.97704572 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.93758902 |
| 85 | MP0001177_atelectasis | 0.93419871 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.92447215 |
| 87 | MP0003631_nervous_system_phenotype | 0.92337940 |
| 88 | MP0001790_abnormal_immune_system | 0.90623579 |
| 89 | MP0005387_immune_system_phenotype | 0.90623579 |
| 90 | MP0008874_decreased_physiological_sensi | 0.90489806 |
| 91 | MP0001919_abnormal_reproductive_system | 0.90322549 |
| 92 | MP0003122_maternal_imprinting | 0.89711893 |
| 93 | MP0004043_abnormal_pH_regulation | 0.89381718 |
| 94 | MP0000685_abnormal_immune_system | 0.88259171 |
| 95 | MP0008872_abnormal_physiological_respon | 0.88021191 |
| 96 | MP0002152_abnormal_brain_morphology | 0.87420509 |
| 97 | MP0000613_abnormal_salivary_gland | 0.87209949 |
| 98 | MP0002229_neurodegeneration | 0.85863296 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.85862266 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.85449748 |
| 101 | MP0005310_abnormal_salivary_gland | 0.83949601 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.83653074 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.83555797 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.80754926 |
| 105 | * MP0002069_abnormal_eating/drinking_beha | 0.80226100 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.80042371 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.79727377 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.79208549 |
| 109 | MP0000026_abnormal_inner_ear | 0.79020842 |
| 110 | MP0004885_abnormal_endolymph | 0.76529664 |
| 111 | MP0002653_abnormal_ependyma_morphology | 0.76009606 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.75616933 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.75303001 |
| 114 | MP0008789_abnormal_olfactory_epithelium | 0.74908058 |
| 115 | MP0001835_abnormal_antigen_presentation | 0.74245891 |
| 116 | MP0005535_abnormal_body_temperature | 0.74242695 |
| 117 | MP0004085_abnormal_heartbeat | 0.71939783 |
| 118 | MP0003632_abnormal_nervous_system | 0.71413648 |
| 119 | MP0000371_diluted_coat_color | 0.71251378 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.70622272 |
| 121 | MP0003698_abnormal_male_reproductive | 0.69460635 |
| 122 | MP0005367_renal/urinary_system_phenotyp | 0.69439420 |
| 123 | MP0000516_abnormal_urinary_system | 0.69439420 |
| 124 | MP0005266_abnormal_metabolism | 0.69352193 |
| 125 | MP0002723_abnormal_immune_serum | 0.69347168 |
| 126 | MP0005171_absent_coat_pigmentation | 0.69205984 |
| 127 | MP0002163_abnormal_gland_morphology | 0.68501941 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.68330100 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.67848449 |
| 130 | MP0002090_abnormal_vision | 0.65318409 |
| 131 | MP0005410_abnormal_fertilization | 0.65193418 |
| 132 | MP0001661_extended_life_span | 0.64847011 |
| 133 | MP0000749_muscle_degeneration | 0.63534112 |
| 134 | MP0009053_abnormal_anal_canal | 0.63493332 |
| 135 | MP0003252_abnormal_bile_duct | 0.62737717 |
| 136 | MP0003950_abnormal_plasma_membrane | 0.62732239 |
| 137 | MP0005000_abnormal_immune_tolerance | 0.62699642 |
| 138 | MP0003137_abnormal_impulse_conducting | 0.62615289 |
| 139 | MP0001664_abnormal_digestion | 0.59669559 |
| 140 | MP0002160_abnormal_reproductive_system | 0.56697270 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.55300885 |
| 142 | MP0003634_abnormal_glial_cell | 0.54296954 |
| 143 | MP0001943_abnormal_respiration | 0.52080772 |
| 144 | MP0003690_abnormal_glial_cell | 0.49674001 |
| 145 | MP0002102_abnormal_ear_morphology | 0.48444079 |
| 146 | * MP0010769_abnormal_survival | 0.46908680 |
| 147 | MP0004233_abnormal_muscle_weight | 0.46078816 |
| 148 | * MP0002082_postnatal_lethality | 0.46052573 |
| 149 | * MP0010770_preweaning_lethality | 0.46052573 |
| 150 | MP0003045_fibrosis | 0.45443110 |
| 151 | * MP0003956_abnormal_body_size | 0.45392620 |
| 152 | MP0005379_endocrine/exocrine_gland_phen | 0.44790883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.49004783 |
| 2 | Atonic seizures (HP:0010819) | 6.44861362 |
| 3 | Febrile seizures (HP:0002373) | 6.28787037 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.94223289 |
| 5 | Focal seizures (HP:0007359) | 5.86192509 |
| 6 | Myokymia (HP:0002411) | 5.80905818 |
| 7 | Absence seizures (HP:0002121) | 4.76725219 |
| 8 | Visual hallucinations (HP:0002367) | 4.74735165 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.48481664 |
| 10 | Hyperventilation (HP:0002883) | 4.47167540 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.39043989 |
| 12 | Progressive inability to walk (HP:0002505) | 4.32722246 |
| 13 | Dialeptic seizures (HP:0011146) | 4.16181859 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.93024620 |
| 15 | Broad-based gait (HP:0002136) | 3.73014838 |
| 16 | Congenital sensorineural hearing impairment (HP:0008527) | 3.64836160 |
| 17 | Popliteal pterygium (HP:0009756) | 3.57770519 |
| 18 | Pancreatic cysts (HP:0001737) | 3.38929262 |
| 19 | Aplasia of the musculature (HP:0100854) | 3.33608793 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.21843679 |
| 21 | Inability to walk (HP:0002540) | 3.21471623 |
| 22 | Dysdiadochokinesis (HP:0002075) | 3.20404073 |
| 23 | Absent speech (HP:0001344) | 3.15424469 |
| 24 | Abnormal social behavior (HP:0012433) | 3.10434813 |
| 25 | Impaired social interactions (HP:0000735) | 3.10434813 |
| 26 | Action tremor (HP:0002345) | 3.06094733 |
| 27 | Type 2 muscle fiber atrophy (HP:0003554) | 3.05621034 |
| 28 | Abnormality of binocular vision (HP:0011514) | 3.04799214 |
| 29 | Diplopia (HP:0000651) | 3.04799214 |
| 30 | Truncal ataxia (HP:0002078) | 2.99764642 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.97968269 |
| 32 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.97348936 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.95658130 |
| 34 | Agammaglobulinemia (HP:0004432) | 2.91953756 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 2.90748106 |
| 36 | Fetal akinesia sequence (HP:0001989) | 2.89167244 |
| 37 | Scanning speech (HP:0002168) | 2.85526294 |
| 38 | Pancreatic fibrosis (HP:0100732) | 2.84493293 |
| 39 | Increased corneal curvature (HP:0100692) | 2.82034225 |
| 40 | Keratoconus (HP:0000563) | 2.82034225 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.79305651 |
| 42 | Poor eye contact (HP:0000817) | 2.77822410 |
| 43 | Status epilepticus (HP:0002133) | 2.76588640 |
| 44 | Chronic hepatic failure (HP:0100626) | 2.76331610 |
| 45 | Congenital stationary night blindness (HP:0007642) | 2.75576500 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.73427429 |
| 47 | Progressive macrocephaly (HP:0004481) | 2.71956857 |
| 48 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71388051 |
| 49 | Abnormal eating behavior (HP:0100738) | 2.70669764 |
| 50 | Excessive salivation (HP:0003781) | 2.57895381 |
| 51 | Drooling (HP:0002307) | 2.57895381 |
| 52 | Stomach cancer (HP:0012126) | 2.56558520 |
| 53 | True hermaphroditism (HP:0010459) | 2.56301264 |
| 54 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.56100176 |
| 55 | Gait imbalance (HP:0002141) | 2.52133735 |
| 56 | Generalized myoclonic seizures (HP:0002123) | 2.50791590 |
| 57 | Malignant hyperthermia (HP:0002047) | 2.45385001 |
| 58 | Anxiety (HP:0000739) | 2.45282929 |
| 59 | Polyphagia (HP:0002591) | 2.44283181 |
| 60 | Long clavicles (HP:0000890) | 2.43029439 |
| 61 | Amblyopia (HP:0000646) | 2.42301453 |
| 62 | Recurrent sinusitis (HP:0011108) | 2.41896445 |
| 63 | Abolished electroretinogram (ERG) (HP:0000550) | 2.40603678 |
| 64 | Dysmetria (HP:0001310) | 2.40538765 |
| 65 | Depression (HP:0000716) | 2.40458893 |
| 66 | Tubulointerstitial nephritis (HP:0001970) | 2.40124552 |
| 67 | Ankle clonus (HP:0011448) | 2.39916995 |
| 68 | Abnormality of the renal medulla (HP:0100957) | 2.38935200 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.35494717 |
| 70 | Nonprogressive disorder (HP:0003680) | 2.34620313 |
| 71 | Hemiparesis (HP:0001269) | 2.34270996 |
| 72 | Papilledema (HP:0001085) | 2.33798254 |
| 73 | Nephronophthisis (HP:0000090) | 2.33757461 |
| 74 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.33061552 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 2.32294125 |
| 76 | Hyperalaninemia (HP:0003348) | 2.32294125 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32294125 |
| 78 | Methylmalonic acidemia (HP:0002912) | 2.31166126 |
| 79 | Absent phalangeal crease (HP:0006109) | 2.30626492 |
| 80 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.26175158 |
| 81 | Abnormality of B cell number (HP:0010975) | 2.25163315 |
| 82 | Tubular atrophy (HP:0000092) | 2.25052723 |
| 83 | Mitochondrial inheritance (HP:0001427) | 2.24832381 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 2.21906758 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.21783033 |
| 86 | Muscle fiber atrophy (HP:0100295) | 2.21687771 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.21595890 |
| 88 | Abnormality of placental membranes (HP:0011409) | 2.20509286 |
| 89 | Amniotic constriction ring (HP:0009775) | 2.20509286 |
| 90 | Protruding tongue (HP:0010808) | 2.20258940 |
| 91 | Abnormality of the neuromuscular junction (HP:0003398) | 2.19972807 |
| 92 | Fatigable weakness (HP:0003473) | 2.19972807 |
| 93 | Acute encephalopathy (HP:0006846) | 2.19269491 |
| 94 | Morphological abnormality of the middle ear (HP:0008609) | 2.18330592 |
| 95 | Abnormality of midbrain morphology (HP:0002418) | 2.17440505 |
| 96 | Molar tooth sign on MRI (HP:0002419) | 2.17440505 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17221658 |
| 98 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17137869 |
| 99 | Akinesia (HP:0002304) | 2.15595794 |
| 100 | Short 1st metacarpal (HP:0010034) | 2.15574431 |
| 101 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.15574431 |
| 102 | Tubulointerstitial abnormality (HP:0001969) | 2.15334712 |
| 103 | Mutism (HP:0002300) | 2.14668812 |
| 104 | Esotropia (HP:0000565) | 2.14421441 |
| 105 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.13950283 |
| 106 | Methylmalonic aciduria (HP:0012120) | 2.12859891 |
| 107 | Hemiplegia (HP:0002301) | 2.12421498 |
| 108 | Pendular nystagmus (HP:0012043) | 2.10649260 |
| 109 | Colon cancer (HP:0003003) | 2.09967303 |
| 110 | Enlarged kidneys (HP:0000105) | 2.08309663 |
| 111 | Impaired vibratory sensation (HP:0002495) | 2.06034343 |
| 112 | Blue irides (HP:0000635) | 2.04848632 |
| 113 | Abnormality of the nasal septum (HP:0000419) | 2.04266412 |
| 114 | Abnormal finger flexion creases (HP:0006143) | 2.03585026 |
| 115 | Hip dysplasia (HP:0001385) | 2.03293986 |
| 116 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02799992 |
| 117 | Absent/shortened dynein arms (HP:0200106) | 2.02799992 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02273707 |
| 119 | Pheochromocytoma (HP:0002666) | 2.01556293 |
| 120 | Hypsarrhythmia (HP:0002521) | 2.01132936 |
| 121 | Horizontal nystagmus (HP:0000666) | 2.00763660 |
| 122 | Carpal bone hypoplasia (HP:0001498) | 2.00432951 |
| 123 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00141223 |
| 124 | Genetic anticipation (HP:0003743) | 1.99468145 |
| 125 | Recurrent bronchitis (HP:0002837) | 1.97516482 |
| 126 | Fair hair (HP:0002286) | 1.96964186 |
| 127 | Chorioretinal atrophy (HP:0000533) | 1.96420953 |
| 128 | Hematochezia (HP:0002573) | 1.96173995 |
| 129 | Panhypogammaglobulinemia (HP:0003139) | 1.93761119 |
| 130 | Abnormality of the renal collecting system (HP:0004742) | 1.93726677 |
| 131 | Specific learning disability (HP:0001328) | 1.93583400 |
| 132 | Cystic liver disease (HP:0006706) | 1.93533979 |
| 133 | Impaired smooth pursuit (HP:0007772) | 1.93504336 |
| 134 | Cutaneous finger syndactyly (HP:0010554) | 1.92662123 |
| 135 | Nemaline bodies (HP:0003798) | 1.92275399 |
| 136 | Constricted visual fields (HP:0001133) | 1.91587292 |
| 137 | Stereotypic behavior (HP:0000733) | 1.91532889 |
| 138 | Decreased central vision (HP:0007663) | 1.90676214 |
| 139 | IgG deficiency (HP:0004315) | 1.90667414 |
| 140 | Generalized hypopigmentation of hair (HP:0011358) | 1.89784510 |
| 141 | Vaginal atresia (HP:0000148) | 1.89325503 |
| 142 | Optic disc pallor (HP:0000543) | 1.89144569 |
| 143 | Abnormality of DNA repair (HP:0003254) | 1.85979413 |
| 144 | Genital tract atresia (HP:0001827) | 1.85960000 |
| 145 | Abnormality of salivation (HP:0100755) | 1.84883539 |
| 146 | Abnormality of the 1st metacarpal (HP:0010009) | 1.84845390 |
| 147 | Neuroendocrine neoplasm (HP:0100634) | 1.84355713 |
| 148 | Bradykinesia (HP:0002067) | 1.83811504 |
| 149 | Thyroiditis (HP:0100646) | 1.81443030 |
| 150 | Distal arthrogryposis (HP:0005684) | 1.79910473 |
| 151 | Hypoplastic ischia (HP:0003175) | 1.79874116 |
| 152 | Clumsiness (HP:0002312) | 1.79833102 |
| 153 | Failure to thrive in infancy (HP:0001531) | 1.79390431 |
| 154 | Spastic gait (HP:0002064) | 1.79312233 |
| 155 | Resting tremor (HP:0002322) | 1.78756442 |
| 156 | Abnormality of the ischium (HP:0003174) | 1.78704268 |
| 157 | Gait ataxia (HP:0002066) | 1.78435293 |
| 158 | Ectopic kidney (HP:0000086) | 1.78257335 |
| 159 | Abnormal ciliary motility (HP:0012262) | 1.78237304 |
| 160 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.78218244 |
| 161 | Retinal dysplasia (HP:0007973) | 1.74978854 |
| 162 | Short tibia (HP:0005736) | 1.74320460 |
| 163 | Abnormality of chromosome stability (HP:0003220) | 1.74111748 |
| 164 | Gowers sign (HP:0003391) | 1.74060447 |
| 165 | Postural instability (HP:0002172) | 1.72956738 |
| 166 | Small hand (HP:0200055) | 1.72821245 |
| 167 | X-linked dominant inheritance (HP:0001423) | 1.72037315 |
| 168 | Cutaneous syndactyly (HP:0012725) | 1.71992888 |
| 169 | Increased CSF lactate (HP:0002490) | 1.70928259 |
| 170 | Spastic tetraplegia (HP:0002510) | 1.70617439 |
| 171 | Hypoplastic iliac wings (HP:0002866) | 1.70508652 |
| 172 | Calf muscle hypertrophy (HP:0008981) | 1.70328048 |
| 173 | Lissencephaly (HP:0001339) | 1.70118050 |
| 174 | Lipid accumulation in hepatocytes (HP:0006561) | 1.69470492 |
| 175 | Intention tremor (HP:0002080) | 1.69456213 |
| 176 | Narrow nasal bridge (HP:0000446) | 1.66881003 |
| 177 | Psychosis (HP:0000709) | 1.66710167 |
| 178 | Cortical visual impairment (HP:0100704) | 1.66663706 |
| 179 | Poor suck (HP:0002033) | 1.66244245 |
| 180 | Widely spaced teeth (HP:0000687) | 1.65151500 |
| 181 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.64905837 |
| 182 | Supranuclear gaze palsy (HP:0000605) | 1.61654930 |
| 183 | Poor coordination (HP:0002370) | 1.60352565 |
| 184 | Distal lower limb amyotrophy (HP:0008944) | 1.59885559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.73867915 |
| 2 | MAP2K7 | 4.07333239 |
| 3 | NTRK3 | 4.06144572 |
| 4 | MAP3K4 | 3.91759877 |
| 5 | CASK | 3.85820922 |
| 6 | MUSK | 3.23217232 |
| 7 | MAP3K12 | 3.21204471 |
| 8 | MAP3K9 | 2.83497281 |
| 9 | PDK2 | 2.78589733 |
| 10 | EPHA4 | 2.67479330 |
| 11 | BRD4 | 2.64696688 |
| 12 | TNIK | 2.63652216 |
| 13 | ADRBK2 | 2.56031910 |
| 14 | GRK1 | 2.54358670 |
| 15 | MAP2K4 | 2.33890273 |
| 16 | MINK1 | 2.25288253 |
| 17 | PIK3CG | 2.14701619 |
| 18 | MARK1 | 2.13923665 |
| 19 | DAPK2 | 2.11793994 |
| 20 | NTRK2 | 2.06770833 |
| 21 | PNCK | 1.98834581 |
| 22 | TAOK3 | 1.91063127 |
| 23 | CDK19 | 1.89554000 |
| 24 | STK38L | 1.87396807 |
| 25 | ZAK | 1.86453320 |
| 26 | CAMKK2 | 1.79610790 |
| 27 | PLK2 | 1.74701860 |
| 28 | DAPK1 | 1.74196166 |
| 29 | ACVR1B | 1.70050218 |
| 30 | NTRK1 | 1.64435460 |
| 31 | MAP4K2 | 1.58849641 |
| 32 | NUAK1 | 1.56905871 |
| 33 | CAMKK1 | 1.54769665 |
| 34 | PRPF4B | 1.54332255 |
| 35 | PAK6 | 1.50404088 |
| 36 | TLK1 | 1.43185377 |
| 37 | EIF2AK3 | 1.41122119 |
| 38 | MAP3K6 | 1.39820705 |
| 39 | STK39 | 1.38665199 |
| 40 | CCNB1 | 1.35627703 |
| 41 | GRK5 | 1.35317047 |
| 42 | NLK | 1.34196012 |
| 43 | TEC | 1.33923454 |
| 44 | MAPK13 | 1.30172138 |
| 45 | CDK5 | 1.29725732 |
| 46 | RIPK4 | 1.26146653 |
| 47 | MAP2K2 | 1.24444281 |
| 48 | CDK8 | 1.22251305 |
| 49 | MAP2K1 | 1.19738859 |
| 50 | FES | 1.16102385 |
| 51 | NME1 | 1.15976796 |
| 52 | BMPR2 | 1.14649746 |
| 53 | SYK | 1.13515184 |
| 54 | OXSR1 | 1.12547073 |
| 55 | IKBKE | 1.11799573 |
| 56 | ERBB4 | 1.11573970 |
| 57 | ARAF | 1.09170406 |
| 58 | PRKCG | 1.05570552 |
| 59 | AKT3 | 1.05447035 |
| 60 | CAMK2A | 1.04225719 |
| 61 | CAMK1 | 1.01620601 |
| 62 | BMPR1B | 0.97870436 |
| 63 | INSRR | 0.97432753 |
| 64 | CSNK1A1L | 0.97225267 |
| 65 | TNK2 | 0.96177096 |
| 66 | CAMK1G | 0.95249413 |
| 67 | TXK | 0.93748277 |
| 68 | SGK2 | 0.91729867 |
| 69 | STK38 | 0.89837330 |
| 70 | CSNK1G1 | 0.87096741 |
| 71 | KSR1 | 0.85390713 |
| 72 | BLK | 0.84419857 |
| 73 | PRKCE | 0.83616560 |
| 74 | IKBKB | 0.82702365 |
| 75 | MAP4K1 | 0.81784975 |
| 76 | WNK3 | 0.80220876 |
| 77 | TRIM28 | 0.79900128 |
| 78 | STK11 | 0.79522391 |
| 79 | MST4 | 0.78736237 |
| 80 | FER | 0.77162730 |
| 81 | SGK494 | 0.75712069 |
| 82 | SGK223 | 0.75712069 |
| 83 | CSNK1G3 | 0.74183051 |
| 84 | SIK2 | 0.73772155 |
| 85 | KSR2 | 0.73764686 |
| 86 | RPS6KB1 | 0.70848340 |
| 87 | LATS2 | 0.70685902 |
| 88 | PRKCQ | 0.69592876 |
| 89 | DYRK1A | 0.69568417 |
| 90 | MKNK2 | 0.68727384 |
| 91 | SGK1 | 0.68590729 |
| 92 | ABL1 | 0.67379949 |
| 93 | MARK3 | 0.63378312 |
| 94 | STK3 | 0.62328765 |
| 95 | LMTK2 | 0.61972671 |
| 96 | CAMK2B | 0.60366592 |
| 97 | RPS6KA5 | 0.60194945 |
| 98 | MAPK7 | 0.59185923 |
| 99 | BTK | 0.58111646 |
| 100 | HCK | 0.57965260 |
| 101 | CSF1R | 0.57357212 |
| 102 | KIT | 0.57123351 |
| 103 | CDK18 | 0.56677149 |
| 104 | LYN | 0.55862034 |
| 105 | MAPKAPK3 | 0.54839702 |
| 106 | PINK1 | 0.54609760 |
| 107 | ITK | 0.53904859 |
| 108 | TSSK6 | 0.53358689 |
| 109 | MAPK12 | 0.52824201 |
| 110 | SIK3 | 0.52602478 |
| 111 | CDK15 | 0.52409334 |
| 112 | PDK1 | 0.52232268 |
| 113 | SGK3 | 0.51526384 |
| 114 | PHKG1 | 0.50140576 |
| 115 | PHKG2 | 0.50140576 |
| 116 | PRKD3 | 0.49669217 |
| 117 | MYLK | 0.49041261 |
| 118 | PIK3CA | 0.48977038 |
| 119 | PRKCH | 0.48787405 |
| 120 | MELK | 0.47307104 |
| 121 | PAK3 | 0.46628233 |
| 122 | CAMK4 | 0.46600729 |
| 123 | IRAK1 | 0.46527674 |
| 124 | BCR | 0.45371347 |
| 125 | RAF1 | 0.45161543 |
| 126 | ADRBK1 | 0.45025813 |
| 127 | CDK14 | 0.44871370 |
| 128 | MAP3K13 | 0.43930006 |
| 129 | BRAF | 0.43375633 |
| 130 | OBSCN | 0.43333767 |
| 131 | EPHA3 | 0.43290730 |
| 132 | PTK2B | 0.43173778 |
| 133 | VRK1 | 0.42897244 |
| 134 | CDK11A | 0.42230233 |
| 135 | UHMK1 | 0.42215588 |
| 136 | PRKACA | 0.41897252 |
| 137 | RET | 0.41555804 |
| 138 | CAMK2G | 0.40843885 |
| 139 | PDPK1 | 0.40672483 |
| 140 | PIM1 | 0.40006756 |
| 141 | TIE1 | 0.38550491 |
| 142 | MAP3K14 | 0.38118875 |
| 143 | RPS6KA3 | 0.36718729 |
| 144 | CSNK1A1 | 0.36655124 |
| 145 | CSNK1D | 0.36636498 |
| 146 | CSNK1G2 | 0.36494373 |
| 147 | MAP3K7 | 0.36430768 |
| 148 | PKN1 | 0.36141825 |
| 149 | CAMK2D | 0.35803721 |
| 150 | IRAK2 | 0.35623811 |
| 151 | DAPK3 | 0.33377775 |
| 152 | MOS | 0.31455417 |
| 153 | NEK6 | 0.31340148 |
| 154 | TYRO3 | 0.30659173 |
| 155 | ALK | 0.29999979 |
| 156 | PRKG1 | 0.29950163 |
| 157 | RPS6KA2 | 0.29370345 |
| 158 | PRKCB | 0.29165017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.18463556 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.90489702 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.96493091 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.94143966 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.83639974 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82548208 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.80016287 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.71819900 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.71053559 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.65177810 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62250334 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.57235248 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.52663063 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49063225 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48113784 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.30368481 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29701579 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 2.16174794 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 2.08551992 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.99554825 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.96640336 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94041330 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.92529403 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91943152 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77059940 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75987159 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.74229502 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67913123 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65085251 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64698442 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.61153411 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59233711 |
| 33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.57259782 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55087024 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54142248 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.54134551 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52161565 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.51049427 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50369091 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46776390 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.43055690 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42748177 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.42041368 |
| 44 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40859600 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.37628163 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37234306 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.36753792 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29263540 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28029487 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27878157 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21607913 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.20890484 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17573847 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14714003 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14326119 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09833493 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08986743 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08763196 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07406834 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06713054 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06469111 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05544683 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03689940 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03461069 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02394173 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02121651 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00726242 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98471847 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96430223 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94972310 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93833318 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93818616 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93314134 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91712373 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91481695 |
| 76 | Gap junction_Homo sapiens_hsa04540 | 0.90677577 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88972693 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88306981 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86416970 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.85509623 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80000110 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78655456 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77265050 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.75777087 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75672629 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75189103 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74975646 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74937621 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74653940 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74217469 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73843791 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72076016 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70313669 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66743801 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66580631 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65550760 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65499157 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.64681800 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64512728 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63415043 |
| 101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62201041 |
| 102 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61996806 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60539186 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.59749083 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59481871 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.57210663 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56565671 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56427157 |
| 109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56117871 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.56036011 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56004207 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55263461 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53018885 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51873100 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51639809 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51109331 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50654732 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48749618 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48257751 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47883619 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47244131 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47229687 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46087546 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.45932621 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45535459 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45512404 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43883172 |
| 128 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43299361 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42148256 |
| 130 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41776570 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41639527 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41617016 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41027227 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39763905 |
| 135 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39480527 |
| 136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38970138 |
| 137 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37920557 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35040469 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32595836 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30555564 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27824777 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26985805 |
| 143 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25228569 |
| 144 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22668769 |
| 145 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21135605 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.20467960 |
| 147 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18733544 |
| 148 | Tuberculosis_Homo sapiens_hsa05152 | 0.18681177 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17770560 |
| 150 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17636274 |
| 151 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17340067 |
| 152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17172988 |
| 153 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16921207 |
| 154 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16613840 |

